Erica Jordan's most recent trade in Revance Therapeutics Inc was a trade of 2,392 Common Stock done at an average price of $3.8 . Disclosure was reported to the exchange on April 16, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Revance Therapeutics Inc
|
Erica Jordan | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 3.80 per share. | 16 Apr 2024 | 2,392 | 114,864 (0%) | 0% | 3.8 | 9,096 | Common Stock |